Teva Pharmaceutical Industries (TEVA) Amortization of Goodwill (2017 - 2024)

Teva Pharmaceutical Industries has disclosed Amortization of Goodwill across 3 years of filings, most recently posting $280.0 million for Q4 2024.

• Quarterly Amortization of Goodwill changed N/A year-over-year to $280.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $280.0 million (down 78.12% YoY) and the FY2024 annual result came in at $1.3 billion, up 82.86% from the prior year.
• Amortization of Goodwill retreated to $280.0 million in Q4 2024, from $600.0 million in the prior quarter.
• Over five years, Amortization of Goodwill peaked at $600.0 million in Q3 2024 and troughed at $280.0 million in Q4 2024.